{"id":1934,"date":"2021-02-01T10:05:14","date_gmt":"2021-02-01T08:05:14","guid":{"rendered":"https:\/\/wits-vida.org\/wordpress21\/?p=1934"},"modified":"2022-03-25T10:03:41","modified_gmt":"2022-03-25T08:03:41","slug":"key-questions-answered-novavax","status":"publish","type":"post","link":"https:\/\/wits-vida.org\/podcasts\/key-questions-answered-novavax\/","title":{"rendered":"Pasha 95: Key questions answered on the results of the Novavax vaccine trials"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-audio fusion-audio-1 audio-container\" style=\"--awb-progress-color:#ffffff;--awb-border-color:var(--awb-color1);--awb-background-color:#1d242d;--awb-max-width:100%;--awb-border-size:0;--awb-border-top-left-radius:0px;--awb-border-top-right-radius:0px;--awb-border-bottom-right-radius:0px;--awb-border-bottom-left-radius:0px;\"><!--[if lt IE 9]><script>document.createElement('audio');<\/script><![endif]-->\n<audio class=\"wp-audio-shortcode\" id=\"audio-1934-1\" autoplay=\"1\" preload=\"auto\" style=\"width: 100%;\" controls=\"controls\"><source type=\"audio\/mpeg\" src=\"https:\/\/wits-vida.org\/wordpress21\/wp-content\/uploads\/novavax-madhi-final-version.mp3?_=1\" \/><a href=\"https:\/\/wits-vida.org\/wordpress21\/wp-content\/uploads\/novavax-madhi-final-version.mp3\">https:\/\/wits-vida.org\/wordpress21\/wp-content\/uploads\/novavax-madhi-final-version.mp3<\/a><\/audio><\/div><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-two text-cap\" style=\"--awb-margin-top:45px;--awb-font-size:22px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:22;line-height:1.15;\"><p class=\"title style-scope ytd-video-primary-info-renderer\">Efficacy of The Novavax Vaccine Trials<\/p><\/h2><\/div><div class=\"fusion-text fusion-text-1\"><p>Novavax vaccine trials run in South Africa and the UK indicate that its efficacy in the\u00a0<a href=\"https:\/\/ir.novavax.com\/news-releases\/news-release-details\/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3\" target=\"_blank\" rel=\"noopener\">UK was 89%<\/a>\u00a0at least 7 days after individuals had received two doses of vaccine. In South Africa, the vaccine efficacy was\u00a0<a href=\"https:\/\/ir.novavax.com\/news-releases\/news-release-details\/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3\" target=\"_blank\" rel=\"noopener\">60% in people living without HIV<\/a>.<\/p>\n<p>The trial is being viewed as highly significant because it is the first vaccine to be tested on a particular COVID-19 variant first identified in South Africa.<\/p>\n<p>In today\u2019s episode of Pasha Shabir Madhi, professor of vaccinology and director of the vaccines and infectious diseases analytics research unit at the University of the Witwatersrand, explains the results as well as the context of this and other vaccine trials.<\/p>\n<\/div><div class=\"fusion-text fusion-text-2\"><p><em>Source : <a href=\"https:\/\/theconversation.com\/pasha-95-key-questions-answered-on-the-results-of-the-novavax-vaccine-trials-154402\" target=\"_blank\" rel=\"noopener\">The Conversation &#8211; Pasha 95: Key questions answered on the results of the Novavax vaccine trials<\/a><\/em><\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"audio","meta":{"rank_math_lock_modified_date":false,"footnotes":""},"categories":[54,39,58],"tags":[12,13,34],"class_list":["post-1934","post","type-post","status-publish","format-audio","hentry","category-podcasts","category-articles","category-news","tag-covid-19","tag-vaccine-coverage","tag-vaccine-rollout","post_format-post-format-audio"],"acf":[],"_links":{"self":[{"href":"https:\/\/wits-vida.org\/wp-json\/wp\/v2\/posts\/1934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wits-vida.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wits-vida.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wits-vida.org\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wits-vida.org\/wp-json\/wp\/v2\/comments?post=1934"}],"version-history":[{"count":5,"href":"https:\/\/wits-vida.org\/wp-json\/wp\/v2\/posts\/1934\/revisions"}],"predecessor-version":[{"id":2130,"href":"https:\/\/wits-vida.org\/wp-json\/wp\/v2\/posts\/1934\/revisions\/2130"}],"wp:attachment":[{"href":"https:\/\/wits-vida.org\/wp-json\/wp\/v2\/media?parent=1934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wits-vida.org\/wp-json\/wp\/v2\/categories?post=1934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wits-vida.org\/wp-json\/wp\/v2\/tags?post=1934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}